Darbepoetin Alfa Administered Every Three Weeks Is Effective for the Treatment of Chemotherapy-Induced AnemiaRalph V. Boccia, Peter T. Silberstein, Randall Liu et al.|The Oncologist|2006Cited by 40
Evaluating the effectiveness of darbepoetin alfa 300 mcg Q3W for the treatment of chemotherapy-induced anemiaRalph V. Boccia, G. Otterson, D. Liu et al.|Journal of Clinical Oncology|2005Cited by 7
An Evaluation of the Effectiveness of Darbepoetin alfa 300 mcg Every 3 Weeks (Q3W) on Clinical Outcomesin Cancer Patients with Chemotherapy-Induced Anemia.Ralph V. Boccia, G. A. Otterson, Delong Liu et al.|Blood|2004Cited by 2
Effectiveness of Darbepoetin alfa Administered Every 3 Weeks on Clinical Outcomes in Patients with Hematologic Malignancies and Chemotherapy-Induced Anemia.Ralph V. Boccia, G. A. Otterson, Dianne Tomita et al.|Blood|2005Cited by 1